CELG - Celgene Corporation Stock Performance Guide

Amount Invested	Date	# of Shares Purchased	# of Shares on 12-31-19	Stock Price on 12-31-19	Total Value on 12-31-19
$5,000	7-28-1987	434.7826	10,434.7824	$124.19*	$1,295,895.63
$5,000	1-2-1990	645.1613	15,483.8712	$124.19*	$1,922,941.96
$5,000	1-3-1995	952.3810	22,857.1440	$124.19*	$2,838,628.71
$5,000	1-3-2000	73.8689	1,772.8536	$124.19*	$220,170.69
$5,000	1-3-2005	190.1141	760.4564	$124.19*	$94,441.08
$5,000	1-4-2010	89.7022	179.4044	$124.19*	$22,280.23
$5,000	1-2-2015	44.0451	44.0451	$124.19*	$5,469.96

*In 2019, Bristol-Myers Squibb (BMY) acquired Celegene Corporation (CELG). CELG shareholders received 1 share of BMY and $60.00 in cash for every share of CELG held.

If you had invested $5,000 in Celgene Corporation's (CELG) initial public offering on July 28, 1987, your investment would have grown to over $1.2 million by the end of 2019. However, if you would have waited until 1995 to invest in Celgene, that same $5,000 would have grown to over $2.8 million. In recent years, Celgene's stock has produced very nice returns as well, with $5,000 invested in 2005 growing into over $94,000 by the end of 2019.

All calculations assume all dividends are reinvested to purchase additional shares. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).